ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Lee's Pharmaceutical Holdings Ltd. ?
1
High Management Efficiency with a high ROE of 16.32%
2
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 74.18
3
Positive results in Dec 24
- PRE-TAX PROFIT(Q) At HKD 37.6 MM has Grown at 833.82%
- NET PROFIT(Q) At HKD 30.62 MM has Grown at 5,170.4%
- ROCE(HY) Highest at 5.04%
4
With ROE of 14.79%, it has a Very Attractive valuation with a 0.65 Price to Book Value
- Over the past year, while the stock has generated a return of 15.63%, its profits have risen by 6.8% ; the PEG ratio of the company is 0.7
- At the current price, the company has a high dividend yield of 248.6
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Lee's Pharmaceutical Holdings Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Lee's Pharmaceutical Holdings Ltd. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Lee's Pharmaceutical Holdings Ltd.
15.62%
0.34
61.88%
Hang Seng Hong Kong
18.06%
0.71
25.51%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.55%
EBIT Growth (5y)
13.25%
EBIT to Interest (avg)
74.18
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.44
Tax Ratio
21.23%
Dividend Payout Ratio
28.46%
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
26.07%
ROE (avg)
16.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.65
EV to EBIT
4.71
EV to EBITDA
4.43
EV to Capital Employed
0.65
EV to Sales
1.06
PEG Ratio
0.66
Dividend Yield
248.62%
ROCE (Latest)
13.72%
ROE (Latest)
14.79%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Lee's Pharmaceutical Holdings Ltd.
Pre-Tax Profit
At HKD 37.6 MM has Grown at 833.82%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 30.62 MM has Grown at 5,170.4%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Net Sales
Highest at HKD 741.62 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Net Sales
At HKD 741.62 MM has Grown at 37.15%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Inventory Turnover Ratio
Highest at 2.21%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
At HKD 77.28 MM has Grown at 9.69%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for Lee's Pharmaceutical Holdings Ltd.
Operating Cash Flow
Lowest at HKD 355.8 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Interest
Highest at HKD 7.4 MM
in the last five periods and Increased by 9.08% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Raw Material Cost
Grown by 9.87% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
